1Burrows L, Taxtter P. Effect of blood transfusion on clolonic malignancy recurrent rate [ J ]. Lancet, 1982,2 : 662 -669,.
2Jensen LS, Hokland M, Nielsen HI. Arandomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery [J]. Br J Surg,1996,83(7) :973 -977.
3Landers B, Dennis F, Hill M, et al.Blood transfusion - induced immunomodulation [ J ]. 1996,82 : 187 - 204.
4Klein HG. Immunomodulatory aspects of transfusion: a once and future risk?[ J ]. Anesthesiology, 1999,91 ( 3 ) :861 - 865.
5Kao KJ. Mechanisms and new approaches for the allogeneic blood transfusion - induced immunomodulatory effects[J]. Transfus Med Bey, 2000,14( 1 ):12 -22.
6Uchida H, Tanaka H, Kitoh Y, et al.Mechanisms of immunomodulation induced by blood transfusion: identification of humoral factors [ J ]. Transplant Proc, 2000,32(2) :255 -256.
7Garter U, Kalechman Y, Sredni B, et al.Induction of a subpopulation of suppressor cells by a single blood transfusion[J]. Kidney Int, 1992,41 (1):143 -148.
8Brown E, Lloyd L, Sheth A, et al.Effect of resuscitation solutions on the immune status of dogs in hemorrhagic shock[ J ]. Am Surg , 1995,61(8) :669 - 672.
9Tartter PI, Burrows L, Kirschner P.Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset NO ) non -oat cell lung cancer [ J ]. J Thorac Cardiovasc Surg, 1984,88(5 Pt 1) :659 -662.
10Vamvakas EC. Transfusion - associated cancer recurrence and postoperative infection : metaanalysis of randomized,controlled clinical trials [ J ]. Transfusion, 1996,36 : 175 - 186.
同被引文献23
1赫捷,赵平,陈万青,等.2011中国肿瘤登记年报.北京:军事医学科学出版社,2012:195.
2World Health Organization-Department of Essential Health Technologies. Blood transfusion safety [ M/OL ] [ 2010-02-23 ]. http ://www. who. int/bloodsafety/en/Blood _ Transfusion _ Salt. pdf.
3Corwin HL, Shorr AF. Red blood cell transfusion in the critically ill: when is it time to say enough.'? . Crit Care Med, 2009, 37: 2114- 2116.
4Carson JL. Transfusion triggers: state of the art in 2010. Acta Anaesthesiol Belg,2010, 61 : 145.
6Calabrich A, Katz A. Management of anemia in cancer patients. Future Oncol, 2011,7 : 507-517.
7Dunne JR, Malone D, Tracy JK, et al. Perioperative anemia: an independent risk factor for infection, mortality and resource utilization in surgery. J Surg Res, 2002, 102: 237-244.
8Shen JG, Cheong JH, Huyng WJ, et al. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. J Surg Oncol, 2005, 91: 126-130.
9Aapro M, Spivak JL. Update on erythropoiesis-stimulating agents and clinical trials in oncology. Oncologist, 2009, 14 Suppl 1 : 6-15.
10Piccioli A, Lensing AW, Prins MH,et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Hacmost,2004,2: 884-889.
